106 related articles for article (PubMed ID: 6163695)
21. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.
Sone S; Fidler IJ
Cell Immunol; 1981 Jan; 57(1):42-50. PubMed ID: 7214534
[No Abstract] [Full Text] [Related]
22. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
Boyer CM; Kreider JW; Bartlett GL
Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
[TBL] [Abstract][Full Text] [Related]
23. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
Fike RM; van Oss CJ
Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
[TBL] [Abstract][Full Text] [Related]
24. Rat adenocarcinoma 13762 expresses tumor rejection antigens but tumor-bearing animals exhibit tumor-specific immunosuppression.
Frey AB; Appleman LJ
Clin Immunol Immunopathol; 1993 Nov; 69(2):223-33. PubMed ID: 8403560
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
North SM; Steck PA; Nicolson GL
Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
[TBL] [Abstract][Full Text] [Related]
26. Stimulatory effect of vitamin A on tumoricidal activity of rat alveolar macrophages.
Tachibana K; Sone S; Tsubura E; Kishino Y
Br J Cancer; 1984 Mar; 49(3):343-8. PubMed ID: 6704311
[TBL] [Abstract][Full Text] [Related]
27. Early local reaction and lymph node permeation of rat carcinoma HH9-cl 14 cells. An immunohistological approach.
Grundmann E; Vollmer E
Pathol Res Pract; 1985 Jan; 179(3):304-9. PubMed ID: 3920647
[TBL] [Abstract][Full Text] [Related]
28. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.
Barlozzari T; Leonhardt J; Wiltrout RH; Herberman RB; Reynolds CW
J Immunol; 1985 Apr; 134(4):2783-9. PubMed ID: 3871818
[TBL] [Abstract][Full Text] [Related]
29. The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma.
Haskill JS; Key M; Radov LA; Parthenais E; Korn JH; Fett JW; Yamamura Y; DeLustro F; Vesley J; Gant G
J Reticuloendothel Soc; 1979 Oct; 26(4):417-25. PubMed ID: 316009
[No Abstract] [Full Text] [Related]
30. Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. I. Characteristics of inhibition and evidence for an infectious agent.
Campbell DA; Manders EK; Oehler JR; Bonnard GD; Oldham RK; Herberman RB
Cell Immunol; 1977 Oct; 33(2):364-77. PubMed ID: 144021
[No Abstract] [Full Text] [Related]
31. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
Lampert F; Nitzschke U; Zwergel T
Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
[TBL] [Abstract][Full Text] [Related]
32. An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells.
Sagar SM; Price KJ
J Neurooncol; 1995; 23(1):15-21. PubMed ID: 7623067
[TBL] [Abstract][Full Text] [Related]
33. Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor cells.
Kilbourn RG; Klostergaard J; Lopez-Berestein G
J Immunol; 1984 Nov; 133(5):2577-81. PubMed ID: 6481163
[TBL] [Abstract][Full Text] [Related]
34. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
Harlos JP; Weiss L
Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
[TBL] [Abstract][Full Text] [Related]
35. Resistance to a transplantable rat mammary tumor (DMBA 8BT) after pre-treatment with syngeneic fetal cells.
Cocuzzi E; Kellen JA
Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):405-8. PubMed ID: 674823
[TBL] [Abstract][Full Text] [Related]
36. [The inhibition of the electrophoretic-mobility-test: an in vitro assay for the estimation of activities in anti-lymphokine and anti-lymphocyte sera (author's transl)].
Werner H; Friemel H; Holzheidt G
Allerg Immunol (Leipz); 1982; 28(1):47-51. PubMed ID: 6214173
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.
Hoon DB; Ziola B; Ramshaw I
Cancer Res; 1984 Jun; 44(6):2406-9. PubMed ID: 6722781
[TBL] [Abstract][Full Text] [Related]
38. Ethanol increases tumor progression in rats: possible involvement of natural killer cells.
Yirmiya R; Ben-Eliyahu S; Gale RP; Shavit Y; Liebeskind JC; Taylor AN
Brain Behav Immun; 1992 Mar; 6(1):74-86. PubMed ID: 1571604
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages.
North SM; Nicolson GL
Cancer Res; 1985 Apr; 45(4):1453-8. PubMed ID: 3978611
[TBL] [Abstract][Full Text] [Related]
40. Macrophages and T lymphocytes infiltrating the rat mammary carcinoma HH9-cl 14 in progressive and regressive tumor growth. An immunohistological study.
Vollmer E; Shimamoto F; Krieg V; Grundmann E
J Cancer Res Clin Oncol; 1986; 111(1):13-9. PubMed ID: 3485100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
